Vincenzo Sforza
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Response to Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 10, 2026
Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the I-STOP study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 25, 2025
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 17, 2025
An ISO 31000-Based Risk Matrix for Risk Management in Anticancer Drug Prescription, Compounding, and Administration for Lung Cancer Patients Treated in a Day Hospital Setting.
Journal: Risk management and healthcare policy
Published: October 02, 2025
Correction: Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer.
Journal: Oncotarget
Published: August 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Journal: Journal for immunotherapy of cancer
Published: July 31, 2025
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 10, 2025
Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: March 17, 2025
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2025
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
Journal: Nature reviews. Clinical oncology
Published: December 20, 2024
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Journal: Frontiers in immunology
Published: September 05, 2023
Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working.
Journal: Exploration of targeted anti-tumor therapy
Published: June 23, 2023
Last Updated: 09/26/2026